
Inveready
Description
Inveready, founded in 2008 and headquartered in Barcelona, Spain, stands as a prominent alternative asset manager in the Iberian Peninsula. The firm distinguishes itself by offering a comprehensive suite of financing solutions designed to support companies across their entire lifecycle, from nascent startups to mature enterprises. This broad mandate allows Inveready to engage with a diverse array of businesses, providing capital and strategic guidance tailored to specific growth stages and industry needs, solidifying its reputation as a versatile and impactful investor.
The firm operates through a multi-strategy approach, encompassing Venture Capital, Growth Equity, Debt, and Private Equity funds. This diversified structure enables Inveready to invest in various sectors, with a strong emphasis on technology, life sciences, and industrial companies. As of early 2024, Inveready boasts an impressive portfolio of over 180 companies, underscoring its significant footprint in the European investment landscape. Furthermore, the firm manages over €1 billion in assets, solidifying its position as a major player in alternative investments and demonstrating its capacity to deploy substantial capital.
Inveready's venture capital arm primarily targets early-stage technology and biotech companies, typically participating in seed, Series A, and Series B rounds. For these initial equity investments, their typical first cheque sizes range from approximately $540,000 (€500,000) for very early-stage ventures up to $5,400,000 (€5,000,000) for more developed early-growth companies. Beyond equity, Inveready also provides flexible debt solutions and engages in private equity transactions for more established businesses, demonstrating its commitment to long-term partnerships and fostering growth throughout a company's evolution. The firm also has a strong track record of over 60 successful exits, highlighting its ability to identify and nurture promising ventures to a successful conclusion.
Investor Profile
Inveready has backed more than 189 startups, with 11 new investments in the last 12 months alone. The firm has led 95 rounds, about 50% of its total and boasts 30 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series Unknown, Series A rounds (top funding stages).
- Majority of deals are located in Spain, United States, United Kingdom.
- Strong thematic focus on Software, Biotechnology, Health Care.
- Led 5 rounds in the past year.
- Typical check size: $540K – $5.4M.
Stage Focus
- Seed (34%)
- Series Unknown (32%)
- Series A (12%)
- Pre Seed (5%)
- Debt Financing (5%)
- Series B (2%)
- Post Ipo Equity (2%)
- Convertible Note (2%)
- Private Equity (2%)
- Undisclosed (1%)
Country Focus
- Spain (86%)
- United States (5%)
- United Kingdom (4%)
- Canada (2%)
- France (1%)
- Denmark (1%)
- Greece (1%)
- Germany (1%)
- Switzerland (1%)
- Italy (1%)
Industry Focus
- Software
- Biotechnology
- Health Care
- Information Technology
- Pharmaceutical
- Internet
- Medical
- E-commerce
- Manufacturing
- Artificial Intelligence (Ai)
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.